![Margareta Elisabeth Björk](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Margareta Elisabeth Björk
Directeur/Membre du Conseil chez
CAMURUS AB
Fortune : 2 M $ au 31/05/2026
Profil
Margareta Elisabeth Björk currently serves as Director at Vicore Pharma AB, Camurus AB (starting 2025), Chalmers University of Technology, Vicore Pharma Holding AB (starting 2023), Björks Matematik o Mera AB, Rfidcompare Europe AB, Betula Consulting AB, and Hansa Biopharma AB (starting 2025).
She is also an Independent Non-Executive Director at Pharvaris NV since 2021.
Former roles include Director at Albireo Ltd., Independent Director at Rocket Pharmaceuticals, Inc. from 2020 to 2026, Independent Non-Executive Director at Calliditas Therapeutics AB, Director at Chalmers Ventures AB from 2018 to 2023, Head of the Diabetes & Endocrinology Unit at Uppsala University Hospital, Senior VP & Head of Late Stage Development at AstraZeneca PLC, and Associate Professor at the University of Uppsala.
Education includes doctorates from Karolinska Institutet and the University of Uppsala.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
PHARVARIS N.V. 0,07 % | 20/05/2026 | 50 530 ( 0,07 % ) | 2 M $ | 31/05/2026 |
VICORE PHARMA HOLDING AB 0,01 % | 31/12/2025 | 30 652 ( 0,01 % ) | 38 841 $ | 31/05/2026 |
| 24/03/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Margareta Elisabeth Björk
| Sociétés | Poste | Début |
|---|---|---|
| PHARVARIS N.V. | Directeur/Membre du Conseil | 01/12/2021 |
| VICORE PHARMA HOLDING AB | Directeur/Membre du Conseil | 01/01/2023 |
| CAMURUS AB | Directeur/Membre du Conseil | 01/01/2025 |
| HANSA BIOPHARMA AB | Directeur/Membre du Conseil | 02/09/2025 |
Vicore Pharma AB
 Vicore Pharma AB Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Directeur/Membre du Conseil | - |
Rfidcompare Europe AB | Directeur/Membre du Conseil | - |
Björks Matematik o Mera AB | Directeur/Membre du Conseil | - |
Chalmers University of Technology
 Chalmers University of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Directeur/Membre du Conseil | - |
Anciens postes connus de Margareta Elisabeth Björk
| Sociétés | Poste | Fin |
|---|---|---|
| ROCKET PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 20/05/2026 |
| ░░░░░░░░ ░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░ ░░░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Formation de Margareta Elisabeth Björk
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
30
Relations au 1er degré
16
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 16 |
|---|---|
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Karolinska Institutet
 Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Chalmers University of Technology
Chalmers University of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Uppsala
 University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vicore Pharma AB
Vicore Pharma AB Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Calliditas Therapeutics AB
 Calliditas Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
Camurus AB
 Camurus AB Pharmaceuticals: MajorHealth Technology Provides nanoscale drug delivery systems for development of high value therapeutics | Health Technology |
Albireo Ltd.
 Albireo Ltd. Pharmaceuticals: MajorHealth Technology Develops therapies that address medical needs in the gastrointestinal and liver disease area | Health Technology |
Hansa Biopharma AB
 Hansa Biopharma AB Pharmaceuticals: MajorHealth Technology Develops therapies and medicines for the treatment of immunomodulatory | Health Technology |
Vicore Pharma Holding AB
 Vicore Pharma Holding AB Pharmaceuticals: MajorHealth Technology Engages in research and development of drugs for lung diseases | Health Technology |
Uppsala University Hospital
 Uppsala University Hospital Hospital/Nursing ManagementHealth Services Operates hospital | Health Services |
Chalmers Ventures AB
 Chalmers Ventures AB Investment ManagersFinance Chalmers Ventures invests in companies located in Sweden. The firm targets companies operating in the field of technology sector. It provides financing for pre-seed, seed & growth stage capital requirements with an investment size of up to SEK 1 million in pre-seed stage, up to SEK 5 million in seed stage and up to SEK 20 million in growth stage transactions. It also act as co-investor. | Finance |
Pharvaris NV
 Pharvaris NV BiotechnologyHealth Technology Develops and commercializes oral bradykinin B2 receptor antagonists | Health Technology |
Rocket Pharmaceuticals, Inc.
 Rocket Pharmaceuticals, Inc. BiotechnologyHealth Technology Provides gene therapy services | Health Technology |
Björks Matematik o Mera AB | |
Rfidcompare Europe AB |
